Audit says MD Anderson Cancer Center mismanaged Watson partnership; Icahn takes stake in BMS; Sarepta sells priority review voucher to Gilead
Dennis Urbaniak has also been named chief digital officer at Havas Lynx.
Pharma industry remains focused on Alzheimer's, despite setbacks; few new diabetes drugs in development; the FDA issues complete response letter to Trevena
The campaign would require a two-fold approach: Facebook link ads and Facebook Audience Network.
Drugmakers are becoming much more cautious with their budgets, WebMD executives said.
Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March
The FDA approves Valeant's psoriasis drug; PhRMA to review its membership criteria; Lions Health announces pharma and health and wellness jury presidents
Novo Nordisk appoints new CEO, and more people moves for you to know about
Pharma execs raise concerns about Trump's plans for the FDA; Merck ends study of experimental Alzheimer's drug; Amgen seeks new indication for Blincyto
Acorda CEO Ron Cohen applauded Marathon's move to pause the commercial activities for its new DMD drug.